Bivalent boosters provided better protection against severe COVID-19
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
USDA-ARS scientists announded developing new tests, new ways to track COVID In wild and domestic animals
On Feb. 7, 2023, the U.S. Department of Agricultureï¾’s Research Service announced that it was implementing a $300…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | WHO | Women's Health
WHO launched new roadmap on breast cancer
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
Study identified features that may make motor neurons vulnerable to ALS
On Feb. 2, 2023, a team of researchers supported by the National Institutes of Health found evidence linking…
Biotechnology | Disease | Life Science News | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
New MRI method provided detailed view of the placenta during pregnancy
On Feb. 1, 2023, researchers funded by the National Institutes of Health announded they had developed a new…
A 19-Year-Old Adolescent with Probable Alzheimer’s Disease
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
FDA announced Evusheld is not currently authorized for emergency use in the U.S.
On Jan. 26, 2023, the U.S. Food and Drug Administration revised the Emergency Use Authorization for Evusheld (tixagevimab…
Twist Bioscience began shipping commercial product from synthetic DNA manufacturing factory of the future
On Jan. 26, 2023, Twist Bioscience announced that it had begun offering high-quality synthetic DNA using its silicon…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Life Science News | Vaccine
U.S. household spread of flu more than doubled during the 2021-2022 season compared to pre-COVID-19 pandemic levels
On Jan. 26, 2023, Centers for Disease Control and Prevention (CDC) reported that U.S. household spread of flu…
Roche launched COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant
On Jan. 25, 2023, Roche and its subsidiary TIB Molbiol announced they had developed a COVID-19 PCR test…
Risk of developing heart failure much higher in rural areas vs. urban
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
OHSU researchers found immune response to COVID-19 strengthens over time
On Jan. 25, 2023, researchers at Oregon Health & Science University (OHSU) reported that Immunity from COVID-19 appears…
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Life Science History | Therapeutics
Milestones in CRISPR
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
Special drone collects environmental DNA from trees
On Jan. 19, 2023, researchers at ETH Zurich and the Swiss Federal research institute WSL announced they had…
Novavax Nuvaxovid COVID-19 vaccine approved in South Korea as an adult booster
On Jan. 18, 2023, Novavax announced that partner SK bioscience had received expanded manufacturing and marketing approval from…
Biotechnology | HIV | Life Science News | NIH | Vaccine
Experimental HIV vaccine regimen safe but ineffective, study found
On Jan. 18, 2023, the National Institutes of Health (NIH) announced that an investigational HIV vaccine regimen tested…
USDA researchers developed naturally fire-resistant cotton lines
On Jan. 18, 2023, researchers at the U.S. Department of Agriculture’s Agricultural Research Service announced they had bred…
Moderna announced mRNA-1345, an investigational RSV Vaccine, met primary efficacy endpoints in phase 3 trial
On Jan. 17, 2023, Moderna announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of…
Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Veterinary
Three grizzly bears tested positive for highly pathogenic avian influenza in Montana
On Jan. 17, 2023, the Montana Fish and Wildlife Commission (FWP) reported that juvenile grizzly bears tested positive…
University of Wisconsin and TGen researchers used machine learning to make early detection of cancerm more accessible
On Jan. 13, 2023, a team of researchers including faculty at the Translational Genomics Research Institute (TGen), part…
Uganda declared end of Ebola disease outbreak
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
Roche announced EC approval of Xofluza for treatment and prevention of influenza in children aged one year and above
On Jan. 11, 2023, Roche announced treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza. Post-exposure prophylaxis…
Single booster dose with updated bivalent COVID-19 vaccine provides broad protection against COVID-19 including Omicron variant
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
United Nations reported that a child or youth died once every 4.4 seconds in 2021
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
Paxlovid reduced serious risks from Omicron variants
On Jan. 10, 2023, the U.S. National Institutes of Health (NIH) reported that antiviral treatments can help reduce…
BD, CerTest Biotec announced Emergency Use Authorization for Mpox diagnostic test
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
Purdue Center for Cancer Research renamed Purdue Institute for Cancer Research
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
FDA granted accelerated approval for Alzheimerï¾’s disease treatment
On Jan. 6, 2023, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway…
BioNTech announced strategic partnership with UK Government to provide up to 10,000 patients with personalized mRNA cancer immunotherapies
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…